The store will not work correctly when cookies are disabled.
(Z)-5-(2,4-dimethylphenyl)-3-(4-methyl-3-nitrobenzylidene)furan-2(3H)-one
ID: ALA4447041
Chembl Id: CHEMBL4447041
PubChem CID: 2277448
Max Phase: Preclinical
Molecular Formula: C20H17NO4
Molecular Weight: 335.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C2=C/C(=C/c3ccc(C)c([N+](=O)[O-])c3)C(=O)O2)c(C)c1
Standard InChI: InChI=1S/C20H17NO4/c1-12-4-7-17(14(3)8-12)19-11-16(20(22)25-19)9-15-6-5-13(2)18(10-15)21(23)24/h4-11H,1-3H3/b16-9-
Standard InChI Key: CIWOSHOAHHIHRM-SXGWCWSVSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 335.36 | Molecular Weight (Monoisotopic): 335.1158 | AlogP: 4.50 | #Rotatable Bonds: 3 |
Polar Surface Area: 69.44 | Molecular Species: ┄ | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.37 | CX LogD: 5.37 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.36 | Np Likeness Score: -0.64 |
References
1. (2012) Entpd5 inhibitors, |